$0.55
Value $58M
HYPR and LLY stock compared: price, dividend, valuation and results, from SEC filings.
$0.55
Value $58M
$1,347.11
Value $1.27T
Hyperfine (HYPR) has a market value of $58M and Eli Lilly and Company (LLY) $1.27T. Over the last year, with dividends, HYPR moved -48.9% and LLY +29.1%. Dividend yield: HYPR none, LLY 0.47%.
The main figures of both. A bar only shows which number is larger, not which is better.
Market value
HYPR$58M
LLY$1.27T
LLY is 21,915 times HYPR
Revenue, 12 months
HYPR$19M
LLY$86.5B
LLY is 4,536 times HYPR
Net income, 12 months
HYPR-$30M
LLY$27.6B
Operating margin
HYPR-167.6%
LLY–
ROIC
HYPR-59.9%
LLY35.5%
95.4 points apart
P/E
HYPR–
LLY46.1
Dividend yield
HYPR0.0%
LLY0.5%
0.5 points apart
5-year return
HYPR-94.5%
LLY+439.5%
534.0 points apart
A fainter bar means a negative number. The 5-year return includes dividends.
Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.
HYPR-94.5%
LLY+439.5%
| Period | HYPRWith dividends | LLYWith dividends |
|---|---|---|
| 1 year since November 19, 2025 | -48.9%Price -48.9% | +29.1%Price +28.3% |
| 3 years since November 20, 2023 | -53.2%-22.4% a yearPrice -53.2% | +130.0%+32.0% a yearPrice +125.4% |
| 5 years since November 19, 2021 | -94.5%-44.0% a yearPrice -94.5% | +439.5%+40.1% a yearPrice +416.7% |
Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.
As on each company's page. A description, not a recommendation: no one figure says which is better.
HYPRHyperfineLLYEli Lilly and Company
| Price | $0.55 | $1,347.11 |
|---|---|---|
| Market value | $58M | $1.27T |
| Enterprise value (EV) | $33M | $1.32T |
| P/E | – | 46.1 |
| P/E, 5-year median | – | 49.9 |
| P/B | 1.8 | 31.6 |
| EV/EBIT | – | 37.8 |
| Free cash flow yield | – | 1.6% |
| Revenue, 12 months | $19M | $86.5B |
|---|---|---|
| Net income, 12 months | -$30M | $27.6B |
| Free cash flow, 12 months | -$28M | $19.7B |
| Earnings per share, 12 months | -$0.29 | $30.81 |
| Revenue growth, year on year | 5.2% | 44.7% |
| Revenue growth a year, past | +115.2%over 5 years | +21.6%over 5 years |
| EPS growth a year, past | – | +27.6%over 5 years |
| Gross margin | 52.7% | 83.6% |
|---|---|---|
| Operating margin | -167.6% | – |
| Net margin | -156.4% | 31.9% |
| ROIC | -59.9% | 35.5% |
| ROE | -87.3% | 88.6% |
| Cash | $38M | $4.9B |
|---|---|---|
| Total debt | $14M | $49.5B |
| Net debt / EBITDA | – | 1.2 |
| Interest cover | – | 38.9× |
| Dividend yield | – | 0.5% |
|---|---|---|
| Dividend per share, 12 months | – | $6.34 |
| Dividend growth a year, past | – | +15.2%over 5 years |
| Buyback yield | – | 0.3% |
| Shareholder yield | – | 0.8% |
Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.
By market value, Eli Lilly and Company ($1.27T) is about 21,914.6 times Hyperfine ($58M), at today's prices.
Since November 19, 2021, HYPR's price moved -94.5% and LLY's +416.7%. With dividends: HYPR -94.5% (-44.0% a year), LLY +439.5% (+40.1% a year). Past returns do not predict future ones.
The dividend yield at today's price is none for Hyperfine and 0.47% for Eli Lilly and Company. Over the last twelve months they paid – and $6.34 per share.
Over the last twelve months, the net margin was -156.4% for Hyperfine and 31.9% for Eli Lilly and Company, and the operating margin -167.6% and –. Revenue was $19M and $86.5B.
The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.
With each of the two, and with the largest in its sector.
The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.
Descriptive data from SEC filings and market prices.